Haverford Trust Company’s iShares Biotechnology ETF IBB Stock Holding History

Haverford Trust Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$850K	Sell	4,470 -360	-7%	-$61.9K	0.01%	253
2026 Q1	$816K	Hold	4,830	–	–	0.01%	244
2025 Q4	$815K	Sell	4,830 -6	-0.1%	-$975	0.01%	246
2025 Q3	$698K	Buy	4,836 +6	+0.1%	+$819	0.01%	254
2025 Q2	$611K	Hold	4,830	–	–	0.01%	269
2025 Q1	$618K	Hold	4,830	–	–	0.01%	267
2024 Q4	$639K	Sell	4,830 -39	-0.8%	-$5.48K	0.01%	258
2024 Q3	$709K	Sell	4,869 -308	-6%	-$44.6K	0.01%	265
2024 Q2	$711K	Hold	5,177	–	–	0.01%	258
2024 Q1	$710K	Buy	5,177 +705	+16%	+$96.3K	0.01%	250
2023 Q4	$608K	Sell	4,472 -45	-1%	-$5.49K	0.01%	254
2023 Q3	$552K	Hold	4,517	–	–	0.01%	244
2023 Q2	$573K	Sell	4,517 -363	-7%	-$47.2K	0.01%	253
2023 Q1	$630K	Buy	+4,880	New	+$639K	0.01%	240

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Haverford Trust Company's IBB Position: Q2 2026 in Review

Haverford Trust Company reduced its iShares Biotechnology ETF (IBB) stake by 7.5% in Q2 2026, selling an estimated $61.9K and leaving 4,470 shares worth $850K. The position accounts for 0.01% of the portfolio, ranked #253.

Haverford Trust Company first reported a position in IBB in Q1 2023 and has held it in 14 quarters since. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Haverford Trust Company held 4,470 shares of iShares Biotechnology ETF worth $850K as of Q2 2026.
Haverford Trust Company sold 360 iShares Biotechnology ETF shares in Q2 2026, an estimated $61.9K.
iShares Biotechnology ETF made up 0.01% of Haverford Trust Company's portfolio in Q2 2026, its #253 holding.
Haverford Trust Company first reported a position in iShares Biotechnology ETF in Q1 2023 and has held it in 14 quarters since.
960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Haverford Trust Company's 13F filing for Q2 2026, filed 12 Aug 2026.